Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Marker Therapeutics, Inc. | VP, Research and Development | Employee Stock Option (right to buy) | 33.2K | Feb 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRKR | Marker Therapeutics, Inc. | Feb 27, 2023 | 1 | $0 | 4 | Mar 1, 2023 | VP, Research and Development |
MRKR | Marker Therapeutics, Inc. | Feb 17, 2022 | 1 | $0 | 4 | Feb 22, 2022 | VP, Research and Development |